Léčba erlotinibem nemocných s nemalobuněčnými karcinomy plic - efekt snížené dávky při závažných nežádoucích účincích

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	Treatment of NSCLC patients with erlotinib. The effect of reduced dose in severe adverse effects.
Authors	PEŠEK Miloš KREJČÍ Jana SKŘIČKOVÁ Jana ZATLOUKAL P.
Year of publication	2009
Type	Article in Proceedings
Conference	Abstrakty XVII. Západočeské pneumoonkologické dny
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	erlotinib; reduced dose; NSCLC treatment
Description	The authors outline the effect of a reduced dose of erlotinib in treatment of NSCLC patients if adverse effects force us to reduce the dose of erlotinib.
Related projects:	Environment - carcinogenesis - oncology